Previous close | 8.20 |
Open | N/A |
Bid | 9.70 |
Ask | 10.20 |
Strike | 195.00 |
Expiry date | 2026-01-16 |
Day's range | 8.20 - 8.20 |
Contract range | N/A |
Volume | |
Open interest | 15 |
Masimo (MASI) collaborates with Cleveland Clinic to boost patient care by combining its Hospital Automation platform with the latter's central patient monitoring platforms.
BD (BDX) announces the commercial launch of its new single-cell research tool, BD Rhapsody ATAC-Seq Assay, to help researchers understand DNA regulation.
Investors are optimistic about Glaukos' (GKOS) strength in its flagship iStent.